Prothena shares increased 3.7% amidst updated analyst price targets and ratings.
Prothena (NASDAQ:PRTA) shares rose 3.7% during mid-day trading on Thursday, with the stock trading as high as $23.70 and last trading at $23.67. Analyst reports on the company include Royal Bank of Canada reducing their price objective to $35, JMP Securities lifting their target price to $85, and HC Wainwright reiterating a "buy" rating with a $90 target price. Cantor Fitzgerald reaffirmed an "overweight" rating for Prothena.
April 13, 2024
3 Articles